{"id":"https://openalex.org/W2160966202","doi":null,"title":"Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.","display_name":"Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.","publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2160966202","mag":"2160966202","pmid":"https://pubmed.ncbi.nlm.nih.gov/9563886"},"language":"en","primary_location":{"id":"pmid:9563886","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9563886","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059219836","display_name":"Nicholas J. Vogelzang","orcid":"https://orcid.org/0000-0002-7665-6079","observed_orcids":["https://orcid.org/0000-0002-7665-6079"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N J Vogelzang","raw_affiliation_strings":["Cancer Research Center, University of Chicago Pritzker School of Medicine, Illinois 60637-1470, USA. njvogelz@mcis.bsd.uchicago.edu","Cancer Research Center, University of Chicago Pritzker School of Medicine, Illinois 60637-1470, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Center, University of Chicago Pritzker School of Medicine, Illinois 60637-1470, USA. njvogelz@mcis.bsd.uchicago.edu","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"Cancer Research Center, University of Chicago Pritzker School of Medicine, Illinois 60637-1470, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054253771","display_name":"Sridhar Mani","orcid":"https://orcid.org/0000-0003-4132-6157","observed_orcids":["https://orcid.org/0000-0003-4132-6157"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Mani","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031299191","display_name":"Richard L. Schilsky","orcid":"https://orcid.org/0000-0003-4474-4303","observed_orcids":["https://orcid.org/0000-0003-4474-4303"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R L Schilsky","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113691807","display_name":"Rafat Ansari","orcid":"https://orcid.org/0000-0003-1958-0861","observed_orcids":["https://orcid.org/0000-0003-1958-0861"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R H Ansari","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013021138","display_name":"David A. Taber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Taber","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063312258","display_name":"S Rhinehart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S N Rhinehart","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J C Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J C Garcia","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007330358","display_name":"Steven C. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S C Meyer","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052264374","display_name":"Rosemarie Mick","orcid":"https://orcid.org/0009-0004-6215-0538","observed_orcids":["https://orcid.org/0009-0004-6215-0538"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Mick","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051856622","display_name":"Bruce Brockstein","orcid":"https://orcid.org/0000-0002-8854-0372","observed_orcids":["https://orcid.org/0000-0002-8854-0372"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B E Brockstein","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088131964","display_name":"Walter Michael Stadler","orcid":"https://orcid.org/0000-0002-0435-2527","observed_orcids":["https://orcid.org/0000-0002-0435-2527"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W M Stadler","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068268371","display_name":"Mark J. Ratain","orcid":"https://orcid.org/0000-0002-0938-4392","observed_orcids":["https://orcid.org/0000-0002-0938-4392"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M J Ratain","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063904421","display_name":"Everett E. Vokes","orcid":"https://orcid.org/0000-0002-8645-8068","observed_orcids":["https://orcid.org/0000-0002-8645-8068"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E E Vokes","raw_affiliation_strings":["The University of Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago,","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":0.2907,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.49473396,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"4","first_page":"929","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7470999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7470999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.06750000268220901,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.03530000150203705,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.6600000262260437},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.878000020980835},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8339999914169312},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serum-chloride","display_name":"serum chloride","score":0.7609999775886536},{"id":"https://openalex.org/keywords/blood-ph","display_name":"blood pH","score":0.8169999718666077},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5720000267028809},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7485628724098206},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7305978536605835},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6733758449554443},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6668633818626404},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6320874691009521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5869489908218384},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.570909857749939},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4834481179714203},{"id":"https://openalex.org/C74133956","wikidata":"https://www.wikidata.org/wiki/Q4669824","display_name":"Absolute neutrophil count","level":4,"score":0.4817073941230774},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4618493616580963},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4302728772163391},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4271085262298584},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40987229347229004}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002452","descriptor_name":"Cell Count","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9563886","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9563886","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2160966202","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9563886","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1165558001","display_name":"COOPERATIVE STUDY","funder_award_id":"U01CA063187","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000865577","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA014599","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G982314443","display_name":"PHASE I &CLINICAL PHARMACOKINETICS - ANTI-CANCER AGENTS","funder_award_id":"n01cm007301-003","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2172063739","https://openalex.org/W2045433422","https://openalex.org/W2321433368","https://openalex.org/W1483594681","https://openalex.org/W2331091104","https://openalex.org/W2049844842","https://openalex.org/W178060685","https://openalex.org/W43260938","https://openalex.org/W1972053246","https://openalex.org/W2184796981"],"abstract_inverted_index":{"Pyrazine":[0],"diazohydroxide":[1],"(PZDH)":[2],"is":[3,80],"a":[4,19,28,40,63,288,309],"novel":[5],"antitumor":[6],"agent":[7],"that":[8,78,265,275],"forms":[9],"DNA":[10],"adducts":[11],"via":[12],"the":[13,45,76,94,142,236,313,338],"reactive":[14],"pyrazine":[15],"diazonium":[16],"ion.":[17],"In":[18],"recent":[20],"Phase":[21,30,98,104],"I":[22],"study":[23],"of":[24,33,96,107,141,165,185,303,356],"PZDH,":[25],"we":[26],"identified":[27],"recommended":[29],"II":[31,99,105],"dose":[32],"100":[34],"mg/m2/day":[35],"x":[36,248,255],"5,":[37,207],"given":[38],"as":[39,350],"5-min":[41],"i.v.":[42],"bolus":[43],"with":[44,115,126,144,148,169,278,334],"cycles":[46],"repeated":[47],"every":[48],"42":[49],"days":[50],"(N.":[51],"J.":[52],"Vogelzang,":[53],"et":[54],"al,":[55],"Cancer":[56],"Res.,":[57],"54:":[58],"114-119,":[59],"1994).":[60],"There":[61,153],"was":[62,167,246,308,318,332],"moderate":[64],"negative":[65],"correlation":[66,202],"between":[67,203,294,321],"serum":[68,221,295,322],"chloride":[69,222,323],"concentration":[70],"and":[71,118,135,139,147,176,183,192,209,215,219,268,297,324],"logarithm":[72],"platelet":[73,216,241,314,339],"nadir,":[74],"suggesting":[75,263],"hypothesis":[77],"PZDH":[79,108,145,166,283,345],"activated":[81],"in":[82,90,109,119,132,158,181,305,312,329,337],"an":[83,327,335,351],"acidic":[84],"environment,":[85],"leading":[86],"to":[87,129,136,347],"more":[88,232,282],"toxicity":[89,164],"acidotic":[91],"patients.":[92],"Therefore,":[93],"University":[95],"Chicago":[97],"cooperative":[100],"network":[101],"conducted":[102],"two":[103],"studies":[106,355],"renal":[110,237,251],"cancer":[111,122,238],"(15":[112],"patients,":[113,124],"2":[114],"liver":[116,127,279],"metastases)":[117,128],"5-fluorouracil-refractory":[120],"colorectal":[121,228,276],"(14":[123],"13":[125],"determine":[130],"efficacy":[131],"each":[133,301],"disease":[134],"correlate":[137],"safety":[138],"tolerance":[140],"drug":[143],"pharmacokinetics/pharmacodynamics":[146],"arterial":[149],"blood":[150,224],"gas":[151],"measurements.":[152],"were":[154,195],"no":[155,200,319],"responses":[156],"seen":[157,180],"either":[159,264],"tumor":[160],"type.":[161],"The":[162,227],"primary":[163],"myelosuppression":[168],"neutropenia":[170],"(absolute":[171],"neutrophil":[172,214],"count,":[173],"<":[174],"1000/microl)":[175],"thrombocytopenia":[177,233,298],"(<50,000":[178],"cells/microl),":[179],"41":[182],"24%":[184],"all":[186],"cycles,":[187],"respectively.":[188],"Other":[189],"grade":[190],"3":[191],"4":[193],"toxicities":[194],"rare.":[196],"Pharmacodynamic":[197],"analysis":[198],"revealed":[199,287],"significant":[201],"plasma":[204],"levels":[205],"at":[206],"60,":[208],"120":[210],"min;":[211],"WBCs;":[212],"absolute":[213],"count":[217],"nadirs;":[218],"initial":[220],"or":[223,274],"pH":[225,296],"levels.":[226],"patients":[229,239,252,277],"experienced":[230,281],"significantly":[231],"than":[234],"did":[235],"(median":[240],"nadir":[242,340],"after":[243],"cycle":[244],"1":[245],"151":[247],"10(3)/microl":[249,256],"for":[250,257,300],"versus":[253],"76":[254],"colon":[258],"patients;":[259],"P":[260],"=":[261,292,342],"0.04),":[262],"prior":[266],"5-fluorouracil":[267],"leucovorin":[269],"reduced":[270],"bone":[271],"marrow":[272],"reserve":[273],"metastases":[280],"toxicity.":[284],"Regression":[285],"analyses":[286],"possible":[289],"relationship":[290,320],"(P":[291,341],"0.06)":[293],"(i.e.,":[299],"increase":[302,311,328,336],"0.03":[304],"pH,":[306],"there":[307,317],"34%":[310],"nadir),":[315],"but":[316],"thrombocytopenia.":[325],"Curiously,":[326],"alkaline":[330],"phosphatase":[331],"associated":[333],"0.02).":[343],"If":[344],"continues":[346],"be":[348],"developed":[349],"antineoplastic":[352],"agent,":[353],"further":[354],"these":[357],"relationships":[358],"are":[359],"suggested.":[360]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}